EVALI Epidemic Continues: Impact and Aftermath

Core Concepts

The long-lasting impact of EVALI on individuals and the ongoing concerns surrounding vaping-related lung injuries.

Abstract

This article delves into the lasting effects of the EVALI epidemic, shedding light on the continued occurrence of vaping-related injuries and the challenges faced by individuals like Rashelle Bernal. It explores the history of EVALI, the diagnostic challenges, and the aftermath experienced by patients. The article emphasizes the need for continued research and tracking of EVALI cases to better understand and address the long-term consequences of vaping-related lung injuries.
Highlights:

Rashelle Bernal's experience with EVALI and the lingering effects on her health.
The rise in diagnoses of vaping-related lung injuries since 2020.
Challenges in diagnosing EVALI and distinguishing it from other conditions.
The lack of comprehensive data tracking and the need for continued research.
The impact of EVALI on mental health and cognitive function in patients.

Stats

In the last three months of 2020, 11,300 medical claims included the U07.0 code.
That figure rose to 22,000 in 2021 and hit 31,600 in 2022.
The CDC in its most recent report from February 2020 said about 80% of patients had used vapes containing THC.

Quotes

"I feel like this is my fault." - Rashelle Bernal
"I know a lot of colleagues who've said that they're still seeing EVALI, but because of COVID-19 they stopped collecting the data." - Bonnie Halpern-Felsher, PhD
"I'm going to ask this patient if they vape when I see the distribution of ground glass appearance." - Ehab Ali, MD

Key Insights Distilled From

Forgotten but Not Gone: EVALI Epidemic Continues

by Lisa Gillesp... at www.medscape.com 04-17-2023

https://www.medscape.com/viewarticle/990888

Deeper Inquiries

How can healthcare professionals improve the identification and diagnosis of EVALI cases?

Healthcare professionals can enhance the identification and diagnosis of EVALI cases by implementing thorough screening protocols. This includes asking patients about their vaping history, even if they may initially deny it. Given that EVALI symptoms can mimic other conditions like viral infections, clinicians should have a high index of suspicion for EVALI, especially in young patients presenting with respiratory symptoms. Utilizing diagnostic tools such as CT scans of the lungs, which can show characteristic patterns of lung damage associated with vaping, can aid in accurate diagnosis. Additionally, creating awareness among healthcare providers about the signs and symptoms of EVALI and the importance of considering vaping as a potential cause of respiratory issues is crucial for early detection and appropriate management.

What are the potential long-term consequences of vaping-related lung injuries on public health?

The long-term consequences of vaping-related lung injuries on public health can be significant. Individuals who have experienced EVALI may continue to suffer from respiratory issues, cognitive impairment, and mood disturbances. Prolonged respiratory problems, such as decreased lung function and chronic inflammation, can impact the quality of life and overall health of affected individuals. Moreover, the psychological toll of dealing with the aftermath of EVALI, including feelings of guilt and self-blame, can lead to mental health challenges. From a public health perspective, the increasing incidence of vaping-related lung injuries poses a threat to population health, especially among young individuals who are more likely to engage in vaping. Addressing the long-term consequences of vaping-related lung injuries requires comprehensive follow-up care, mental health support, and public health interventions to prevent future cases.

How can the stigma associated with EVALI be addressed to provide better support for affected individuals?

Addressing the stigma associated with EVALI is essential to provide better support for affected individuals. Healthcare professionals and the broader community need to recognize that individuals with EVALI are not solely responsible for their condition and should not be blamed or judged. Education and awareness campaigns can help dispel misconceptions about vaping and EVALI, highlighting the risks and consequences associated with these behaviors. Creating a supportive and non-judgmental environment for individuals affected by EVALI, both in healthcare settings and in the community, can encourage open communication and access to necessary care and resources. By promoting empathy, understanding, and evidence-based information, the stigma surrounding EVALI can be reduced, allowing affected individuals to seek help without fear of judgment or discrimination.